Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing" is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include MedPage Today, Oncodaily, 747 Live and Endpoints News. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 142d ago.
Quick answers
Why is "Nature retracts provocative PD-1 study that tied lung cancer survival to treatme" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (5)
- Nature Retracts Cancer Study Suggesting Treatment Is Better Earlier in the Day MedPage Today · 146d ago
- Paolo Tarantino: Nature Medicine Retracts Debated Study on Early Morning Immunotherapy Benefits Oncodaily · 146d ago
- Nature Medicine retracts Chinese lung cancer immunotherapy timing study 747 Live · 146d ago
- Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks Endpoints News · 146d ago
- Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing Fierce Pharma · 146d ago
Topics
Related trends
Permitting Bill Would Charge Data Centers Billions for Power
A new Harvard study reveals 400 U.S. hyperscale data centers now consume electricity equal to entire states like Michigan, while a permitting bill proposes charging operators billions for power infrastructure.
MIT scientists discover a surprising way to boost the brain’s nighttime cleaning system
MIT scientists discover that timed pink noise can boost the brain's impaired nighttime cleaning system during sleep.
Zinc-iodine battery retains nearly all capacity over 1,000 cycles in new study
A new aqueous zinc-iodine battery design retains nearly all of its capacity after more than 1,000 charge cycles, according to research published in Nature.
‘Stop obsessing over eight hours’: New study says another sleep goal is just as key
A new study challenges the traditional eight-hour sleep rule by linking irregular sleep schedules directly to mental health conditions.
Transient nuclear softening for zygotic gene activation in mice
Research reveals mouse embryo nuclei temporarily soften after the first cell division, enabling critical gene activation for development.
Validation of clinical and preclinical obesity across global cohorts
A new diagnostic framework for obesity that adds waist measurements to BMI outperforms BMI alone in identifying health risks and distinguishing clinical from pre-clinical obesity, according to a study of 844,108 adults across four countries published in Nature.